This narrative review explores the evolving role of biomarkers across cardiovascular, renal, neurological, metabolic, metabolic, and respiratory diseases, focusing on their clinical and regulatory contexts of use-diagnostic, prognostic, predictive, surrogate, safety, and pharmacodynamic/response.
Achilleas Livieratos, Laura Goea, V. Das et al.· Therapeutic Innovation and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.